CA1237671A
(en)
*
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
WO1995013796A1
(en)
*
|
1993-11-16 |
1995-05-26 |
Depotech Corporation |
Vesicles with controlled release of actives
|
US5897873A
(en)
*
|
1984-04-12 |
1999-04-27 |
The Liposome Company, Inc. |
Affinity associated vaccine
|
US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
US5019369A
(en)
*
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
US4885172A
(en)
*
|
1985-06-26 |
1989-12-05 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
US5059421A
(en)
*
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
US5171578A
(en)
*
|
1985-06-26 |
1992-12-15 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
US4923854A
(en)
*
|
1986-01-22 |
1990-05-08 |
The Liposome Company, Inc. |
Solubilization of hydrophobic materials using lysophospholipid
|
US6759057B1
(en)
|
1986-06-12 |
2004-07-06 |
The Liposome Company, Inc. |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
CA1320130C
(en)
*
|
1986-06-12 |
1993-07-13 |
Alan L. Weiner |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
AU7543887A
(en)
*
|
1986-06-12 |
1988-01-11 |
Liposome Company, Inc., The |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
US5204112A
(en)
*
|
1986-06-16 |
1993-04-20 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
DE3776763D1
(ja)
*
|
1986-06-16 |
1992-03-26 |
The Liposome Co.,Inc., Princeton, N.J., Us |
|
US4902466A
(en)
*
|
1986-12-11 |
1990-02-20 |
Ciba Corning Diagnostics Corp. |
Process for making lipid films suitable for liposomes
|
ATE141166T1
(de)
*
|
1986-12-23 |
1996-08-15 |
Liposome Co Inc |
Guanidinaminoglycosid enthaltende liposome
|
AU641532B2
(en)
*
|
1986-12-23 |
1993-09-23 |
Liposome Company, Inc., The |
Liposome preparation and antibiotic
|
US5174930A
(en)
*
|
1986-12-31 |
1992-12-29 |
Centre National De La Recherche Scientifique (Cnrs) |
Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
|
US4891324A
(en)
*
|
1987-01-07 |
1990-01-02 |
Syntex (U.S.A.) Inc. |
Particle with luminescer for assays
|
US5723147A
(en)
*
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
US4963297A
(en)
*
|
1987-12-22 |
1990-10-16 |
The Liposome Company, Inc. |
Spontaneous vesticulation of multilamellar liposomes
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
WO1988009170A1
(en)
*
|
1987-05-22 |
1988-12-01 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
JPH03500166A
(ja)
*
|
1987-06-19 |
1991-01-17 |
シラキューズ ユニバーシティ |
チトカラシンの精製方法および組成物
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
JP2710847B2
(ja)
*
|
1987-11-04 |
1998-02-10 |
ネクスター・フアーマシユーテイカルズ・インコーポレイテツド |
中性子捕獲療法剤およびその製法
|
US5328678A
(en)
*
|
1987-11-04 |
1994-07-12 |
Vestar, Inc. |
Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
|
US4913902A
(en)
*
|
1987-11-10 |
1990-04-03 |
North Carolina State University |
Purification by affinity binding to liposomes
|
US5009819A
(en)
*
|
1987-11-12 |
1991-04-23 |
The Liposome Company, Inc. |
Taste moderating composition
|
US5807572A
(en)
*
|
1988-02-18 |
1998-09-15 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
US5019392A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro-Pak, Inc. |
Encapsulation of parasiticides
|
US5948441A
(en)
*
|
1988-03-07 |
1999-09-07 |
The Liposome Company, Inc. |
Method for size separation of particles
|
MX9203504A
(es)
*
|
1988-04-20 |
1992-07-01 |
Liposome Co Inc |
Complejo agente: lipido activo de alta proporcion.
|
AU3564589A
(en)
*
|
1988-05-17 |
1989-12-12 |
Liposome Technology, Inc. |
Preparation of uniform-size liposomes and other lipid structures
|
US4994213A
(en)
*
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
EP0414806B1
(en)
*
|
1988-05-20 |
1994-07-20 |
The Liposome Company, Inc. |
High ratio active agent:lipid complex
|
US5422120A
(en)
*
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
US5269979A
(en)
*
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
CA1340241C
(en)
*
|
1988-06-08 |
1998-12-15 |
Fountain Pharmaceuticals, Inc. |
Method for marking solvent dilution microcarriers
|
US5133965A
(en)
*
|
1988-06-08 |
1992-07-28 |
Fountain Pharmaceuticals, Inc. |
Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
|
US4952405A
(en)
*
|
1988-10-20 |
1990-08-28 |
Liposome Technology, Inc. |
Method of treating M. avium infection
|
AU4525589A
(en)
*
|
1988-10-27 |
1990-05-14 |
Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
US5049392A
(en)
*
|
1989-01-18 |
1991-09-17 |
The Liposome Company, Inc. |
Osmotically dependent vesicles
|
US5139803A
(en)
*
|
1989-02-09 |
1992-08-18 |
Nabisco, Inc. |
Method and liposome composition for the stabilization of oxidizable substances
|
US5015483A
(en)
*
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
DE69026820T2
(de)
*
|
1989-03-31 |
1996-11-28 |
Univ California |
Zubereitung von liposomen- und lipid-komplexzusammensetzungen
|
US5549910A
(en)
*
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
US5077057A
(en)
*
|
1989-04-05 |
1991-12-31 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
US5277914A
(en)
*
|
1989-03-31 |
1994-01-11 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
DE69026380T2
(de)
*
|
1989-06-23 |
1996-10-17 |
Liposome Co Inc |
Zielliposomen und verfahren zur kupplung von liposomen-proteinen
|
US5100662A
(en)
*
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
US5820848A
(en)
*
|
1990-01-12 |
1998-10-13 |
The Liposome Company, Inc. |
Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
|
IT1240353B
(it)
*
|
1990-03-30 |
1993-12-07 |
Poli Ind Chimica Spa |
Formulazioni liposomiali di farmaci immunomodulatori per applicazionelocale ed aerosolica
|
WO1992002244A1
(en)
*
|
1990-07-31 |
1992-02-20 |
The Liposome Company, Inc. |
Accumulation of amino acids and peptides into liposomes
|
CA2047969A1
(en)
*
|
1990-08-17 |
1992-02-18 |
Thomas D. Madden |
Benzoporphyrin vesicles
|
US6623671B2
(en)
|
1990-10-05 |
2003-09-23 |
Royden M. Coe |
Liposome extrusion process
|
US5340716A
(en)
*
|
1991-06-20 |
1994-08-23 |
Snytex (U.S.A.) Inc. |
Assay method utilizing photoactivated chemiluminescent label
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
US5578498A
(en)
|
1991-05-22 |
1996-11-26 |
Behringwerke Ag |
Metal chelate containing compositions for use in chemiluminescent assays
|
US5443813A
(en)
*
|
1991-06-06 |
1995-08-22 |
Associated Universities, Inc. |
Loading and conjugating cavity biostructures
|
AU3423493A
(en)
*
|
1991-12-31 |
1993-07-28 |
Zymogenetics Inc. |
Methods and compositions for reducing blood loss
|
WO1994003812A1
(en)
*
|
1992-07-31 |
1994-02-17 |
Syntex (U.S.A.) Inc. |
Photoactivatable chemiluminescent matrices
|
WO1994012155A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Vestar, Inc. |
Antibiotic formulation and process
|
US5958449A
(en)
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
US5552155A
(en)
*
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
PT688206E
(pt)
*
|
1993-02-26 |
2000-08-31 |
Fountain Pharm Inc |
Sistema de libertacao de vacina e solucao precursora de conservacao prolongada para encapsulacao a distancia de principios activos
|
KR100315213B1
(ko)
*
|
1993-04-02 |
2002-07-03 |
질레스피 카롤 |
리포좀생산방법
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
US5455044A
(en)
*
|
1993-05-14 |
1995-10-03 |
Depotech Corporation |
Method for treating neurological disorders
|
ATE210966T1
(de)
*
|
1993-05-21 |
2002-01-15 |
Liposome Co Inc |
Reduzierung von durch liposome induzierte physiologischen gegenreaktionen
|
CA2166465C
(en)
|
1993-07-08 |
2003-10-14 |
Laura M. Edgerly-Pflug |
Method of controlling the size of liposomes
|
PT725629E
(pt)
*
|
1993-10-25 |
2000-11-30 |
Liposome Co Inc |
Defensinas em lipossomas
|
US5840328A
(en)
*
|
1994-01-11 |
1998-11-24 |
The Liposome Company, Inc. |
Treatment using arachidonic acid metabolite and particulate formulations
|
US5716526A
(en)
*
|
1994-01-14 |
1998-02-10 |
The Liposome Company, Inc. |
Method of separating materials from liposomes or lipid complexes
|
CA2182485A1
(en)
*
|
1994-02-02 |
1995-08-10 |
Yong Wei |
Pharmaceutically active compounds and liposomes, and methods of use thereof
|
ES2119446T3
(es)
*
|
1994-05-23 |
1998-10-01 |
Liposome Co Inc |
Dispositivo de preparacion de formulacion.
|
CA2152765A1
(en)
|
1994-06-30 |
1995-12-31 |
Jeroen Elisabeth-Joseph Knops |
Methods for treating a physiological disorder associated with beta amyloid peptide
|
US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
US5800833A
(en)
*
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
US5824864A
(en)
*
|
1995-05-25 |
1998-10-20 |
Pioneer Hi-Bred International, Inc. |
Maize gene and protein for insect control
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
US6107332A
(en)
|
1995-09-12 |
2000-08-22 |
The Liposome Company, Inc. |
Hydrolysis-promoting hydrophobic taxane derivatives
|
US6051600A
(en)
*
|
1995-09-12 |
2000-04-18 |
Mayhew; Eric |
Liposomal hydrolysis-promoting hydrophobic taxane derivatives
|
JPH10508322A
(ja)
|
1995-10-12 |
1998-08-18 |
スーパーゲン,インコーポレイティド |
5βステロイドのリポソーム配合物
|
US5718917A
(en)
*
|
1995-12-15 |
1998-02-17 |
Harvard Scientific Corporation |
PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
AU682805B1
(en)
*
|
1996-03-22 |
1997-10-16 |
Biosphere Technologies Inc. |
Method for inducing a systemic immune response to an antigen
|
US6015576A
(en)
*
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
US6117449A
(en)
*
|
1996-03-22 |
2000-09-12 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to a hepatitis antigen
|
US6015716A
(en)
*
|
1996-07-12 |
2000-01-18 |
The Liposome Company, Inc. |
Detection of endotoxin levels in liposomes, lipid bilayers and lipid complexes
|
US5997899A
(en)
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
WO1998051278A2
(en)
*
|
1997-05-14 |
1998-11-19 |
Inex Pharmaceuticals Corporation |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
EP2113247A3
(en)
|
1997-05-14 |
2010-05-05 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
CA2296056A1
(en)
*
|
1997-07-10 |
1999-01-21 |
Keith Baker |
Methods for universally distributing therapeutic agents to the brain
|
US6306432B1
(en)
|
1997-09-08 |
2001-10-23 |
Chiron Corporation |
High and low load formulations of IGF-I in multivesicular liposomes
|
JP4467789B2
(ja)
|
1997-09-18 |
2010-05-26 |
パシラ ファーマシューティカルズ インコーポレーテッド |
持続放出性リポソーム麻酔組成物
|
CA2309548A1
(en)
|
1997-11-14 |
1999-05-27 |
Skyepharma Inc. |
Production of multivesicular liposomes
|
US6165997A
(en)
*
|
1997-11-20 |
2000-12-26 |
Statens Serum Institut |
Phospholipids having antimicrobial activity with or without the presence of antimicrobials
|
US6277413B1
(en)
|
1998-07-17 |
2001-08-21 |
Skyepharma, Inc. |
Biodegradable compositions for the controlled release of encapsulated substances
|
DK1105096T3
(da)
|
1998-08-19 |
2004-03-08 |
Skyepharma Canada Inc |
Injicerbare vandige propofoldispersioner
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
AU2002322024B2
(en)
*
|
2001-05-31 |
2008-05-08 |
Pacira Pharmaceuticals, Inc. |
Encapsulation of nanosuspensions in liposomes and microspheres
|
BRPI0105509B8
(pt)
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
|
CA2472055A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Inex Pharmaceuticals Corporation |
Improved mucosal vaccines and methods for using the same
|
US20030180348A1
(en)
*
|
2002-03-22 |
2003-09-25 |
Levinson R. Saul |
Transcellular drug delivery system
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
DK2363114T3
(da)
|
2002-10-29 |
2015-06-22 |
Insmed Inc |
Opretholdt afgivelse af anti-infektionsmidler
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
US20080200539A1
(en)
*
|
2002-11-07 |
2008-08-21 |
Bommarito Alexander A |
Topical antifungal treatment
|
WO2004047800A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
PT1744764E
(pt)
|
2004-04-22 |
2012-08-30 |
Celator Pharmaceuticals Inc |
Formulações lipossómicas de agentes antraciclina e análogos de citidina
|
JP2008506780A
(ja)
|
2004-07-19 |
2008-03-06 |
セレーター ファーマスーティカルズ、インク. |
活性剤放出のための粒子状構築物
|
JP4990786B2
(ja)
|
2004-11-05 |
2012-08-01 |
イネックス ファーマシューティカルズ コーポレイション |
薬物リポソーム製剤を安定化するための組成物および方法
|
WO2006055951A2
(en)
*
|
2004-11-19 |
2006-05-26 |
Portola Pharmaceuticals, Inc. |
Tetrahydroisoquinolines as factor xa inhibitors
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
AU2006308765B2
(en)
|
2005-11-02 |
2013-09-05 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
PT1962805T
(pt)
|
2005-12-08 |
2016-10-05 |
Insmed Inc |
Composições de anti-infeciosos baseadas em lípidos para tratamento de infeções pulmonares
|
US9149543B2
(en)
*
|
2005-12-15 |
2015-10-06 |
The Trustees Of The University Of Pennsylvania |
Methods and models for rapid, widespread delivery of genetic material to the CNS using non-viral, cationic lipid-mediated vectors
|
EP2492278A1
(en)
|
2006-09-18 |
2012-08-29 |
Compugen Ltd. |
Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy
|
WO2008130641A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Biocure, Inc. |
Drug delivery vehicle containing vesicles in a hydrogel base
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
AU2008273813B2
(en)
|
2007-07-12 |
2013-06-13 |
Compugen Ltd. |
Bioactive peptides and method of using same
|
WO2009097011A1
(en)
|
2007-08-17 |
2009-08-06 |
Celator Pharmaceuticals, Inc. |
Improved platinum drug formulations
|
EP2231195B1
(en)
|
2007-12-04 |
2017-03-29 |
Arbutus Biopharma Corporation |
Targeting lipids
|
US9078812B2
(en)
*
|
2007-12-06 |
2015-07-14 |
The Bay Zoltan Foundation For Applied Research |
Particulate drug carriers as desensitizing agents
|
JP5697988B2
(ja)
|
2007-12-27 |
2015-04-08 |
プロチバ バイオセラピューティクス インコーポレイティッド |
干渉rnaを使用したポロ様キナーゼ発現のサイレンシング方法
|
US20110117125A1
(en)
|
2008-01-02 |
2011-05-19 |
Tekmira Pharmaceuticals Corporation |
Compositions and methods for the delivery of nucleic acids
|
WO2009129319A2
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
WO2009127060A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
EP2350043B9
(en)
|
2008-10-09 |
2014-08-20 |
TEKMIRA Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
WO2010041727A1
(ja)
*
|
2008-10-10 |
2010-04-15 |
株式会社リポソーム工学研究所 |
リポソーム製造装置
|
US20110187012A1
(en)
*
|
2008-10-14 |
2011-08-04 |
Hashimoto Electronic Industry Co., Ltd. |
Automatic multifunctional liposome manufacturing device
|
EP3207944B1
(en)
|
2008-11-10 |
2020-01-15 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
EP3243504A1
(en)
|
2009-01-29 |
2017-11-15 |
Arbutus Biopharma Corporation |
Improved lipid formulation
|
CN102316852A
(zh)
|
2009-02-11 |
2012-01-11 |
丽卡实验有限公司 |
脂质胞二磷胆碱注射液
|
JP6032724B2
(ja)
|
2009-03-12 |
2016-11-30 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
脂質製剤組成物およびEg5遺伝子とVEGF遺伝子の発現を阻害する方法
|
AU2010245933B2
(en)
|
2009-05-05 |
2016-06-16 |
Arbutus Biopharma Corporation |
Methods of delivering oligonucleotides to immune cells
|
JP5769701B2
(ja)
|
2009-05-05 |
2015-08-26 |
テクミラ ファーマシューティカルズ コーポレイションTekmira Pharmaceuticals Corporation |
脂質組成物
|
AU2010259984B2
(en)
|
2009-06-10 |
2017-03-09 |
Arbutus Biopharma Corporation |
Improved lipid formulation
|
IL292615B2
(en)
|
2009-07-01 |
2023-11-01 |
Protiva Biotherapeutics Inc |
Nucleic acid-lipid particles, preparations containing them and their uses
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
AP2015008874A0
(en)
|
2009-08-14 |
2015-11-30 |
Alnylam Pharmaceuticals Inc |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
EP2480668A2
(en)
|
2009-09-23 |
2012-08-01 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing genes expressed in cancer
|
WO2011056682A1
(en)
|
2009-10-27 |
2011-05-12 |
The University Of British Columbia |
Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
|
WO2011071860A2
(en)
|
2009-12-07 |
2011-06-16 |
Alnylam Pharmaceuticals, Inc. |
Compositions for nucleic acid delivery
|
AU2010330814B2
(en)
|
2009-12-18 |
2017-01-12 |
Acuitas Therapeutics Inc. |
Methods and compositions for delivery of nucleic acids
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
EP2569276B1
(en)
|
2010-05-12 |
2021-02-24 |
Arbutus Biopharma Corporation |
Novel cationic lipids and methods of use thereof
|
EP3254672A1
(en)
|
2010-06-03 |
2017-12-13 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
US20130323269A1
(en)
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
WO2012016188A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
DK3202760T3
(da)
|
2011-01-11 |
2019-11-25 |
Alnylam Pharmaceuticals Inc |
Pegylerede lipider og deres anvendelse til lægemiddelfremføring
|
EP3456317A1
(en)
|
2011-09-27 |
2019-03-20 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
EP2780456A1
(en)
|
2011-11-17 |
2014-09-24 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Therapeutic rna switches compositions and methods of use
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
EP2606897A1
(en)
|
2011-12-22 |
2013-06-26 |
Laboratorios Del. Dr. Esteve, S.A. |
Methods and compositions for the treatment of diseases caused by enveloped viruses
|
DK2817287T3
(da)
|
2012-02-24 |
2019-01-02 |
Arbutus Biopharma Corp |
Trialkyl kationisk lipid og metoder til anvendelse deraf
|
JP6402097B2
(ja)
|
2012-05-21 |
2018-10-10 |
インスメッド インコーポレイテッド |
肺感染症を処置するためのシステム
|
US11291644B2
(en)
|
2012-09-04 |
2022-04-05 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
MX2015006681A
(es)
|
2012-11-29 |
2016-04-06 |
Insmed Inc |
Formulaciones de vancomicina estabilizadas.
|
CA2919226C
(en)
|
2013-07-23 |
2024-05-14 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
EP3540257B1
(en)
|
2013-08-15 |
2022-07-20 |
Meritor Heavy Vehicle Braking Systems (UK) Limited |
A method of adjusting a brake
|
WO2015166988A1
(ja)
|
2014-04-30 |
2015-11-05 |
富士フイルム株式会社 |
リポソームの製造方法
|
WO2015175939A1
(en)
|
2014-05-15 |
2015-11-19 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
WO2016054421A1
(en)
|
2014-10-02 |
2016-04-07 |
Protiva Biotherapeutics, Inc |
Compositions and methods for silencing hepatitis b virus gene expression
|
EP3302435B1
(en)
|
2015-05-26 |
2023-03-08 |
Plumb Pharmaceuticals, Inc. |
Liposome loading
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
EP3329003A2
(en)
|
2015-07-29 |
2018-06-06 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
US10363226B2
(en)
|
2015-08-12 |
2019-07-30 |
North Carolina State University |
Platelet membrane-coated drug delivery system
|
EP4218739A3
(en)
|
2016-01-08 |
2023-08-09 |
The Regents of The University of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
EP3478838A1
(en)
|
2016-06-30 |
2019-05-08 |
Arbutus Biopharma Corporation |
Compositions and methods for delivering messenger rna
|
TW201936201A
(zh)
|
2017-12-14 |
2019-09-16 |
美商堅固生物科技公司 |
基因之非病毒生產及遞送
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
EP4312536A1
(en)
|
2021-04-01 |
2024-02-07 |
Vestaron Corporation |
Liposome formulations for pesticide delivery and methods for producing and using the same
|
WO2023018990A2
(en)
|
2021-08-12 |
2023-02-16 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
WO2023144792A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
|
WO2024031051A1
(en)
|
2022-08-05 |
2024-02-08 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
WO2024081646A1
(en)
|
2022-10-11 |
2024-04-18 |
Massachusetts Institute Of Technology |
Reagents and methods for the conditional delivery of cargo
|